Literature DB >> 12894065

Predisposing factors and clinical features of eczema herpeticum: a retrospective analysis of 100 cases.

Andreas Wollenberg1, Claudia Zoch, Stefanie Wetzel, Gerd Plewig, Bernhard Przybilla.   

Abstract

BACKGROUND: Eczema herpeticum (EH) is a widespread herpes simplex virus infection of inflamed skin, most often occurring in patients with atopic dermatitis (AD). A monomorphic eruption of dome-shaped blisters and pustules in the eczematous lesions along with severe systemic illness lead to the clinical diagnosis, but atypical variants with disseminated slits may also occur. Topical use of corticosteroids is alleged to be a pathogenetic factor for EH, but predisposing factors for EH are largely unknown. Objective and methods We sought to characterize the clinical features and predisposing factors for EH. A retrospective analysis of 100 patients with EH seen from 1980 through 1996 and of 105 control patients with AD was performed.
RESULTS: Fever and lymphopenia were associated with EH, whereas an increased erythrocyte sedimentation rate was frequently seen in patients with EH and control patients who were impetiginized. In 100 patients with EH, primary herpes simplex virus infection was likely in 20 patients, and a secondary herpes simplex virus infection was suggestive in 26 patients. In all, 13 patients had a second EH, whereas 3 patients had a third EH. Patients with EH had a significantly earlier onset of AD and a significantly higher total serum IgE level than the control patients. More than 75% of the patients with EH had not received corticosteroid treatment in the 4 weeks before onset of EH.
CONCLUSIONS: The characteristics of patients with EH are those associated with severe manifestations of AD. The majority of EH occurs in patients with untreated AD, arguing against a role for topical corticosteroids in the development of EH.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12894065     DOI: 10.1067/s0190-9622(03)00896-x

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  52 in total

1.  Kaposi's varicelliform eruption (eczema herpeticum) in an infant.

Authors:  Sumit Mehndiratta
Journal:  World J Pediatr       Date:  2010-08       Impact factor: 2.764

2.  [Outside-inside or inside-outside? Impaired skin barrier as a primary defect in atopic eczema].

Authors:  S Kamann; T Ruzicka
Journal:  Hautarzt       Date:  2007-01       Impact factor: 0.751

3.  Comorbidity in Atopic Dermatitis.

Authors:  Eric L Simpson
Journal:  Curr Dermatol Rep       Date:  2012-03-01

Review 4.  Tacrolimus ointment: a review of its use in atopic dermatitis and its clinical potential in other inflammatory skin conditions.

Authors:  Dene Simpson; Stuart Noble
Journal:  Drugs       Date:  2005       Impact factor: 9.546

5.  Case 1: A two-year-old boy with fever and widespread vesicular lesions.

Authors:  Kevin Mitchell; Lauren Redgate; Renee Jackson; Justin Lui
Journal:  Paediatr Child Health       Date:  2015-03       Impact factor: 2.253

6.  A case of eczema herpeticum with hailey-hailey disease.

Authors:  Gun Hong Lee; Yun Mi Kim; Sung Yul Lee; Jong Suk Lee; Young Lip Park; Kyu Uang Whang
Journal:  Ann Dermatol       Date:  2009-08-31       Impact factor: 1.444

7.  Association between atopic dermatitis and serious cutaneous, multiorgan and systemic infections in US adults.

Authors:  Shanthi Narla; Jonathan I Silverberg
Journal:  Ann Allergy Asthma Immunol       Date:  2018-01       Impact factor: 6.347

8.  Eczema herpeticum in a patient with terminal renal failure under narrow-band uvb therapy.

Authors:  Lorea Bagazgoitia; Sònia Beà; Maite Garate; Ramón Moreno; Pedro Jaén
Journal:  Indian J Dermatol       Date:  2010 Apr-Jun       Impact factor: 1.494

Review 9.  [Diagnosis and treatment of eyelid eczema. An interdisciplinary challenge].

Authors:  A Wollenberg; K Kerschenlohr; T Pavicic; E M Messmer
Journal:  Hautarzt       Date:  2004-07       Impact factor: 0.751

10.  Eczema herpeticum and clinical criteria for investigating smallpox.

Authors:  David A Boyd; Leonard C Sperling; Scott A Norton
Journal:  Emerg Infect Dis       Date:  2009-07       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.